NCT01541189View on ClinicalTrials.gov

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Hypertension
Interventions
DRUG

Valsartan

80 mg/day for 2 weeks, up-titrated to 160 mg/day for further 8 weeks

Trial Locations (1)

100044

Novartis Investigative Site, Beijing

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY